BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27285764)

  • 21. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
    Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
    J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
    Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
    Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
    Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
    Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
    Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
    EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck.
    Liu FY; Zhao ZJ; Li P; Ding X; Guo N; Yang LL; Zong ZH; Sun CF
    Oncol Rep; 2011 Feb; 25(2):383-91. PubMed ID: 21165563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
    Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
    Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine receptor 7 via proline-rich tyrosine kinase-2 upregulates the chemotaxis and migration ability of squamous cell carcinoma of the head and neck.
    Yang L; Liu F; Xu Z; Guo N; Zheng X; Sun C
    Oncol Rep; 2012 Nov; 28(5):1659-64. PubMed ID: 22923218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2.
    Su YW; Xie TX; Sano D; Myers JN
    PLoS One; 2011 Apr; 6(4):e19412. PubMed ID: 21559372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK; Liu TJ; Frederick MJ; Clayman GL
    Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma.
    Patel MR; Zhao N; Ang MK; Stadler ME; Fritchie K; Weissler MC; Zanation AM; Harris SL; Funkhouser WK; Olshan AF; Shores CG; Hayes DN
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):587-95. PubMed ID: 23846458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
    Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
    Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
    Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
    Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers.
    Wu CL; Kirley SD; Xiao H; Chuang Y; Chung DC; Zukerberg LR
    Cancer Res; 2001 Oct; 61(19):7325-32. PubMed ID: 11585773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
    Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
    Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1.
    Aguero MF; Facchinetti MM; Sheleg Z; Senderowicz AM
    Cancer Res; 2005 Apr; 65(8):3364-73. PubMed ID: 15833870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of the Overexpression of Fatty Acid Metabolism-Related Enzymes in Squamous Cell Carcinoma of the Head and Neck.
    Su YW; Wu PS; Lin SH; Huang WY; Kuo YS; Lin HP
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.